| Autor: |
Kulicke, Werner-Michael, Meyer, Fabian, Bingöl, Ali Ö., Lohmann, Derek |
| Předmět: |
|
| Zdroj: |
AIP Conference Proceedings; 7/7/2008, Vol. 1027 Issue 1, p585-587, 3p, 1 Diagram, 3 Graphs |
| Abstrakt: |
Sodium Hyaluronate (NaHA) is a member of the glycosaminoglycans and is present in the human organism as part of the synovial fluid and the vitreous body. HA is mainly commercialized as sodium or potassium salt. It can be extracted from cockscombs or can be produced by bacterial fermentation ensuring a low protein content. Because of its natural origin and toxicological harmlessness, NaHA is used to a great extent for pharmaceutical and cosmetic products. In medical applications, NaHA is already being used as a component of flushing and stabilizing fluids in the treatment of eye cataract and as a surrogate for natural synovial fluid. Another growing domain in the commercial utilization of NaHA is the field of skin care products like dermal fillers or moisturizers. In this spectrum, NaHA is used in dilute over semidilute up to concentrated (0
|
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
